Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit

Samir Gupta, Gloria D. Coronado, Keith Argenbright, Alison T. Brenner, Sheila F. Castañeda, Jason A. Dominitz, Beverly Green, Rachel B. Issaka, Theodore R. Levin, Daniel S. Reuland, Lisa C. Richardson, Douglas J. Robertson, Amit G. Singal, Michael Pignone

Research output: Contribution to journalArticlepeer-review

77 Scopus citations

Abstract

Uptake of colorectal cancer screening remains suboptimal. Mailed fecal immunochemical testing (FIT) offers promise for increasing screening rates, but optimal strategies for implementation have not been well synthesized. In June 2019, the Centers for Disease Control and Prevention convened a meeting of subject matter experts and stakeholders to answer key questions regarding mailed FIT implementation in the United States. Points of agreement included: 1) primers, such as texts, telephone calls, and printed mailings before mailed FIT, appear to contribute to effectiveness; 2) invitation letters should be brief and easy to read, and the signatory should be tailored based on setting; 3) instructions for FIT completion should be simple and address challenges that may lead to failed laboratory processing, such as notation of collection date; 4) reminders delivered to initial noncompleters should be used to increase the FIT return rate; 5) data infrastructure should identify eligible patients and track each step in the outreach process, from primer delivery through abnormal FIT follow-up; 6) protocols and procedures such as navigation should be in place to promote colonoscopy after abnormal FIT; 7) a high-quality, 1-sample FIT should be used; 8) sustainability requires a program champion and organizational support for the work, including sufficient funding and external policies (such as quality reporting requirements) to drive commitment to program investment; and 9) the cost effectiveness of mailed FIT has been established. Participants concluded that mailed FIT is an effective and efficient strategy with great potential for increasing colorectal cancer screening in diverse health care settings if more widely implemented.

Original languageEnglish (US)
Pages (from-to)283-298
Number of pages16
JournalCA Cancer Journal for Clinicians
Volume70
Issue number4
DOIs
StatePublished - Jul 1 2020

Keywords

  • colorectal cancer (CRC)
  • colorectal neoplasms
  • evidence based
  • fecal immunochemical test (FIT)
  • mailed outreach

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit'. Together they form a unique fingerprint.

Cite this